| Code | 1209F | ||||||||||
| MA number | 44/0309/25-S | ||||||||||
| Product Form: | con inf 50x20 ml/100 mg (liek.inj.skl.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | AGmed s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 27.09.2025 |
| Validity: | 27.09.2030 |
| PIL: |
PIL_Oxaliplatin AGmed 5 mg_ml_09_2025.pdf
|
| SPC: |
SPC_Oxaliplatin AGmed 5 mg_ml_09_2025.pdf
|
| Safety feature | Yes |
| Data update: | 30.09.2025 |
